Eric A Hughes sells 80.8K shares of TEVA for $2.6M at $32.36, reducing stake by 48.5% to 85.6K shares
Hughes executed 2 separate sales totaling 80,762 shares for $2,613,450.24 at $32.36 per share on 2026-03-03, cutting his holdings from 166,378 shares to 85,616 shares—a 48.5% reduction. The transaction occurred near the 52-week high of $36.25 (within 2.2% of peak), at a time when the stock is down 12.4% over 30 days but up 11.6% over 90 days, suggesting a multi-quarter rally. TEVA trades at a P/E of 9.71 with a market cap of $36.5B and recent profitability (net income $433M on $4.5B revenue last quarter), indicating a profitable, established pharma company rather than a turnaround or high-risk play. The materiality and scale of this reduction—liquidating nearly half his position in a single filing date—warrants attention to any disclosed motivation in Remarks and any 10b5-1 plan designation that may constrain inference about timing rationale.